Further studies demonstrated overexpression of DSCAM-AS1 in various other cancer entities, always being associated with poor survival, like in non-small cell lung cancer, colorectal cancer, osteosarcoma, hepatocellular carcinoma and melanoma [19,20,21,22,23]. The gene discussed is DSCAM-AS1; the disease is cancer.